{"id":"W2794419219","doi":"10.1038/nrclinonc.2018.9","title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":673,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Immunotherapy; Bevacizumab; Ipilimumab; Modalities; Cancer immunotherapy; Therapeutic modalities; Oncology; Hypoxia (environmental); Angiogenesis; Cancer; Cancer research; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001228355,0.0007169593,0.001380449,0.000968392,0.0001897056,0.001264767,0.0006655764,0.001283232,0.003926535],"category_scores_gemma":[0.001685804,0.00017145,0.000710097,0.0007820044,0.000443119,0.001123084,0.00054705,0.002410366,0.001038714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004856852,"about_ca_system_score_gemma":0.000898276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004548565,"about_ca_topic_score_gemma":0.001103374,"domain_scores_codex":[0.9997017,0.00007051792,0.00004075601,0.0000558589,0.00008849721,0.00004266007],"domain_scores_gemma":[0.9994341,0.000343476,0.00007372956,0.00001674359,0.00009930966,0.00003258747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001738466,0.00009167616,0.0003759837,0.008657164,0.0002100851,0.0001257488,0.00002591787,0.0004561751,0.001419444,0.007419723,0.03792417,0.9431202],"study_design_scores_gemma":[0.0001556004,0.0003094079,0.001656925,0.00553615,0.0005522966,0.001346698,0.00005301761,0.0003203103,0.001115172,0.007428906,0.9814934,0.0000322964],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001971561,0.9972386,0.0002063925,0.001023901,0.0004241294,0.000005526027,0.00002537092,0.000009384511,0.0008694979],"genre_scores_gemma":[0.002887632,0.9935632,0.0004176645,0.001239255,0.001117016,0.00001732225,0.00005232015,0.000003919239,0.0007017672],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003926535,"threshold_uncertainty_score":0.01313561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07002965191508446,"score_gpt":0.4594774427664584,"score_spread":0.3894477908513739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}